All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Heron Therapeutics Inc., of Redwood City, Calif., closed its underwritten public offering of 4,751,358 shares of common stock at a price of $11.75 per share.